folligen has been researched along with buserelin in 4 studies
| Studies (folligen) | Trials (folligen) | Recent Studies (post-2010) (folligen) | Studies (buserelin) | Trials (buserelin) | Recent Studies (post-2010) (buserelin) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 2,147 | 432 | 161 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajor, T; Balogh, A; Bökönyi, G; Horváth, A; Horváth, J; Kéri, G; Mezö, I; Teplán, I; Vadász, Z; Vántus, T | 1 |
| Kéri, G; Nicholson, RI | 1 |
| Balogh, A; Csuka, O; Kéri, G; Szöke, B; Teplán, I | 1 |
| Teplán, I | 1 |
1 review(s) available for folligen and buserelin
| Article | Year |
|---|---|
Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Topics: Animals; Antineoplastic Agents, Hormonal; Buserelin; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Animal; Neoplasms, Experimental; Oligopeptides; Somatostatin | 2000 |
3 other study(ies) available for folligen and buserelin
| Article | Year |
|---|---|
Novel antitumor peptide hormones and their effect on signal transduction.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Molecular Sequence Data; Peptides; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Signal Transduction; Somatostatin; Tumor Cells, Cultured | 1992 |
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Mammary Neoplasms, Experimental; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Time Factors; Uterus | 1992 |
Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line.
Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Gonadotropin-Releasing Hormone; Humans; Phospholipids; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Thymidine; Tritium; Tumor Cells, Cultured | 1991 |